Skip to content

Opticyte

The World’s Only Cell O₂ Monitor

  • Technology
  • About Us
  • Investors
  • COVID-19
  • News
  • Contact Us

Category: News

  • All
  • All
News

Opticyte Earns FDA Breakthrough Device Designation for the First Cell O2 Patient Monitor for Organ Failure

Posted on January 9, 2023Last Updated: February 25, 2023
News

CEO Lori Arakaki on Working with StarFish Medical

Posted on November 16, 2022Last Updated: February 25, 2023
News

Pacific Northwest Sepsis Conference

Posted on April 29, 2021Last Updated: February 25, 2023
News

CEO Lori Arakaki on Creating Successful Academic Spin-outs

Posted on February 17, 2021Last Updated: February 25, 2023
News

GeekWire: UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure

Lisa Stiffler, GeekWirePosted on January 13, 2021Last Updated: February 25, 2023
News

Opticyte Secures $4.6 Million in Funding to Develop First Cell O2 Monitor for Reducing Organ Failure

Posted on January 13, 2021Last Updated: February 25, 2023
News

Opticyte: Why the Need is Now

Lori Arakaki, CEO & Co-founderPosted on December 11, 2020Last Updated: January 13, 2021
Connect.
  • Follow us on:
  • Twitter
  • LinkedIn

Stay Informed

Find out first about important updates and announcements by signing up to our newsletter.


Opticyte

Opticyte, Inc.
4000 Mason Road, Suite 300
Seattle, WA 98195

Contact Us
  • Technology
  • News
  • About Us
  • Careers
  • Investors
  • Conflict of Interest Policy

Opticyte, Inc.
4000 Mason Road, Suite 300
Seattle, WA 98195


© 2023 Opticyte. All rights reserved.

Website Designed and Built by Wildern Design + Interactive

  • Home
  • Technology
  • About Us
  • Investors
  • News
  • Contact Us